MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume 57, Issue 3, Pages 419-428
Publisher
Wiley
Online
2017-11-16
DOI
10.1002/mc.22765
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- microRNAs: important regulators of stem cells
- (2017) Na Li et al. Stem Cell Research & Therapy
- Transcriptome Sequencing Reveals Key Pathways and Genes Associated with Cisplatin Resistance in Lung Adenocarcinoma A549 Cells
- (2017) Yani Fang et al. PLoS One
- Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
- (2016) D.A. Fennell et al. CANCER TREATMENT REVIEWS
- Challenges and Strategies in Precision Medicine for Non-Small-Cell Lung Cancer
- (2016) Joseph J. Sacco et al. CURRENT PHARMACEUTICAL DESIGN
- MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line
- (2016) Lily Boo et al. International Journal of Biological Sciences
- MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell
- (2016) Jingwen Liu et al. International Journal of Nanomedicine
- Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways
- (2016) Gemma Leon et al. PHARMACOLOGY & THERAPEUTICS
- Spotlight on pembrolizumab in non-small cell lung cancer: the evidence to date
- (2016) Hongbin Chen et al. OncoTargets and Therapy
- Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2
- (2016) Zhiqiang Ye et al. Oncotarget
- The Novel miR-9600 Suppresses Tumor Progression and Promotes Paclitaxel Sensitivity in Non–small-cell Lung Cancer Through Altering STAT3 Expression
- (2016) Cheng-Cao Sun et al. Molecular Therapy-Nucleic Acids
- MiR-30a-5p Overexpression May Overcome EGFR-Inhibitor Resistance through Regulating PI3K/AKT Signaling Pathway in Non-small Cell Lung Cancer Cell Lines
- (2016) Fei Meng et al. Frontiers in Genetics
- The emerging roles of Oct4 in tumor-initiating cells
- (2015) Ying-Jie Wang et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- miR-5100 promotes tumor growth in lung cancer by targeting Rab6
- (2015) Haili Huang et al. CANCER LETTERS
- microRNA regulation of Wnt signaling pathways in development and disease
- (2015) Jia L. Song et al. CELLULAR SIGNALLING
- MicroRNAs: Emerging Role in the Endogenous μ Opioid System
- (2015) Massmo Barbierato et al. CNS & Neurological Disorders-Drug Targets
- CD133+CD44+Cells Mediate in the Lung Metastasis of Osteosarcoma
- (2015) Aina He et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Role of deregulated microRNAs in non-small cell lung cancer progression using fresh-frozen and formalin-fixed, paraffin-embedded samples
- (2015) YAHONG WANG et al. Oncology Letters
- Cancer Stem Cells: Current Status and Evolving Complexities
- (2012) Jane E. Visvader et al. Cell Stem Cell
- RAB6C Is a Retrogene that Encodes a Centrosomal Protein Involved in Cell Cycle Progression
- (2010) Joanne Young et al. JOURNAL OF MOLECULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started